Another recall has been linked to the Novartis pharmaceutical plant in Lincoln. This time, the products being recalled have most likely already been used.
The medication is fine. The problem is that 142 production lots of Triaminic syrups and 41 lots of Theraflu syrups could have defective child-resistant bottle caps. The defect could allow for the removal of the cap without breaking the seal on the bottle.
The company says it received four reports of adverse events related to the Triaminic products.
As of Thursday afternoon, information about specific lots was not available.
The products were made between May 2010 and December 2011. Novartis shut down the plant in December 2011 after federal inspections found numerous quality-control problems.
That discovery led to the recall of some Excederin, Bufferin, NoDoz, and other products.
Later, about 400,000 bottles of the blood pressure medication DynaCirc CR were recalled because of packaging issues.
Novartis shut down the plant in December 2011.
Novartis estimates 97% of the inventory that is under the Triaminic and Theraflu recall has been used, returned or quarantined.